申请人:ACADIA PHARMACEUTICALS, INC.
公开号:US20140221364A1
公开(公告)日:2014-08-07
The present invention relates to tetrahydroquinoline compounds as muscarinic receptor agonists; compositions comprising the same; methods of inhibiting an activity of a muscarinic receptor with said compounds; methods of treating a disease condition associated with a muscarinic receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.
本发明涉及四氢喹啉化合物作为毒蕈碱受体激动剂,包含该化合物的组合物,使用该化合物抑制毒蕈碱受体活性的方法,使用该化合物治疗与毒蕈碱受体相关的疾病状况的方法,以及使用该化合物鉴定适合使用该化合物治疗的受试者的方法。